Leeds Institute of Cancer and Pathology, University of Leeds, , Leeds, UK.
J Clin Pathol. 2014 Mar;67(3):272-5. doi: 10.1136/jclinpath-2013-201854. Epub 2013 Oct 29.
Pathological reporting of breast cancer has evolved alongside scientific advances. Such advances have led to recognition of different molecular classes of breast cancer resulting in improved disease management. The aim of this study was to establish whether these advances could be applied to archival breast cancer cases dating from the 1940s to assess historical trends. Important observations included the marked differences in pathological reporting, size of tumour and in ERα expression throughout the decades.
乳腺癌的病理报告随着科学的进步而发展。这些进展导致了对不同分子类型乳腺癌的认识,从而改善了疾病的管理。本研究的目的是确定这些进展是否可以应用于可追溯到 20 世纪 40 年代的存档乳腺癌病例,以评估历史趋势。重要的观察结果包括在整个几十年中,病理报告、肿瘤大小和 ERα 表达的明显差异。